Advertisement

Pharmacy Report

Ohio reverses hydroxychloroquine ban | 10 most expensive Part B drugs | Appeals court: 340B payment cuts are legal | Sanofi, GSK get up to $2.1B from US for COVID-19 vaccine | Chinese hackers allegedly targeted Moderna's COVID-19 research

August 3, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Ohio pharmacy board reverses hydroxychloroquine ban Full story 2. Moderna's coronavirus vaccine research alleged target of Chinese hackers Full story 3. US to pay Sanofi, GlaxoSmithKline up to $2.1B…

Ohio first state to ban hydroxychloroquine for COVID-19 | US to send Texas 500 cases of remdesivir | Hospitals to spend 3.29% more on drugs in 2021 | Operation Warp Speed: A timeline

July 30, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Ohio's board of pharmacy bans hydroxychloroquine for use in COVID-19 patients Full story 2. Hospitals will spend 3.29% more on drugs in 2021, Vizient projects Full story 3. US…

Moderna, Pfizer start late-stage COVID-19 vaccine trials | These 20 hospitals top US News' Honor Roll | CVS loses 21K patients' info after vandalism | Drug lobbies don't show for White House meeting

July 28, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Moderna, Pfizer begin late-stage COVID-19 vaccine trials Full story 2. CVS Pharmacy loses 21,289 patients' information after vandalism Full story 3. Indivior pleads guilty, agrees to pay $600M to…

Advertisement

Fresenius Kabi recalls sedative | Biogen CFO steps down | 10 drugmakers expected to be most profitable in 5 years | DEA rules leave hospitals short on IV opioids, Premier says

July 23, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Fresenius Kabi recalls sedative, cites possible cross-contamination Full story 2. 10 drugmakers expected to make the most money in the next 5 years Full story 3. DEA rules leave…

US inks $1.95B vaccine distribution deal with Pfizer, BioNTech | FDA: 20 more hand sanitizers may be toxic | 'Enough is enough': APhA wants revamp of pharmacy reimbursements | 10 most valuable pharma R&D projects

July 22, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. 'Enough is enough': APhA CEO calls for pharmacy reimbursement overhaul Full story 2. 10 most valuable R&D projects in the pharmaceutical industry pipeline Full story 3. Pfizer, BioNTech sign…

3 COVID-19 vaccine makers report positive results | Walgreens names CTO | How COVID-19 affected sales at top 15 drugmakers | 2-dose COVID-19 vaccine may complicate immunization efforts

July 21, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Two-dose COVID-19 vaccines could complicate efforts to immunize billions of people Full story 2. Walgreens Boots Alliance appoints new chief technology officer Full story 3. AstraZeneca, U of Oxford…

NIH updates remdesivir guidelines | CVS fined for understaffing, prescription errors | 5 provisions pharmacists want in Congress' next relief package | Novartis to supply COVID-19 drugs to low-income countries

July 20, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. NIH updates remdesivir treatment guidelines Full story 2. J&J to start human trials of its COVID-19 vaccine this week Full story 3. CVS fined for understaffing, prescription errors in…

NSA: Russian hackers target vaccine research | 10 hospitals seeking pharmacy leaders | Hype for COVID-19 vaccine by 2021 is 'grave disservice' to the public, Merck CEO says | 6 key trends in prescription costs, pharmacy spending

July 16, 2020 BHR Newsletter Virtual Events  •  Webinars   •   Recent Whitepapers   •   Podcasts 1. Illinois hospital opens new outpatient pharmacy Full story 2. CoverMyMeds 2020 report: 6 key trends in prescription costs, pharmacy spending Full story 3. Head of Operation Warp Speed won't…

Advertisement